Company
Every investor coverage indicates participated in a round Harro Höfliger raised.
Companies Harro Höfliger acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Harro Höfliger. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of Brisbane medtech firm Vaxxas on scaling its needle-free vaccine patch from prototype toward commercial manufacture, with pharma partner Merck and production specialist Harro Hofliger announced as collaborators.